Difficulty: Medium
Average Score: 85%
Practice
The following antihypertensive drug tends to lower plasma renin activity
Correct answer
A
Rationale
In pharmacology, understanding the mechanism of action of antihypertensive drugs is crucial for effective patient management. In this case, the correct answer is A) Clonidine because it acts centrally to stimulate alpha-2 adrenergic receptors in the brain, leading to a decrease in sympathetic outflow from the central nervous system. This decrease in sympathetic tone results in reduced renin release from the kidneys, ultimately lowering plasma renin activity.
Now, let's analyze why the other options are incorrect:
B) Hydralazine is a direct vasodilator that primarily acts on arterial smooth muscle, causing peripheral vasodilation without significantly affecting renin release.
C) Nifedipine is a calcium channel blocker that works by inhibiting calcium influx into vascular smooth muscle cells, leading to vasodilation. It does not directly impact renin activity.
D) Captopril is an ACE inhibitor that blocks the conversion of angiotensin I to angiotensin II, which leads to decreased aldosterone secretion and vasodilation but does not directly affect renin levels.
In an educational context, knowing how different antihypertensive drugs affect the renin-angiotensin-aldosterone system is essential for tailoring treatment to individual patients based on their specific physiological and pharmacological needs. Understanding the mechanisms of action of these drugs can help healthcare professionals make informed decisions to optimize patient outcomes and minimize adverse effects.
Now, let's analyze why the other options are incorrect:
B) Hydralazine is a direct vasodilator that primarily acts on arterial smooth muscle, causing peripheral vasodilation without significantly affecting renin release.
C) Nifedipine is a calcium channel blocker that works by inhibiting calcium influx into vascular smooth muscle cells, leading to vasodilation. It does not directly impact renin activity.
D) Captopril is an ACE inhibitor that blocks the conversion of angiotensin I to angiotensin II, which leads to decreased aldosterone secretion and vasodilation but does not directly affect renin levels.
In an educational context, knowing how different antihypertensive drugs affect the renin-angiotensin-aldosterone system is essential for tailoring treatment to individual patients based on their specific physiological and pharmacological needs. Understanding the mechanisms of action of these drugs can help healthcare professionals make informed decisions to optimize patient outcomes and minimize adverse effects.